Cellular mechanism of resistance to erythropoietin
- PMID: 8524490
- DOI: 10.1093/ndt/10.supp6.27
Cellular mechanism of resistance to erythropoietin
Abstract
Erythropoiesis is controlled by different regulators. Interleukin 3, granulocyte-macrophage colony-stimulating factor and stem cell factor play regulatory functions in the early steps of erythropoiesis. Erythropoietin (Epo) is the main factor which acts positively on the last steps of the production of erythrocytes in mammals. Epo is specific for the erythroid progenitor cells and has only little effect on other cells. The target cells for Epo are the erythroid progenitors (BFUe and CFUe). Epo acts on these progenitors through surface receptors specific for Epo. Epo induces the proliferation and differentiation of erythroid progenitors leading finally to reticulocytes. During this process, certain conditions are required to permit this differentiation: progenitors must be present in sufficient numbers, the bone marrow environment must be normal, and nutrients such as folic acid, vitamin B12 and particularly iron must be available. Elemental iron is an absolute requirement for adequate haemoglobin formation. Indeed, in a normal adult, without any stimulation, the bone marrow synthesizes 4 x 10(14) molecules of haemoglobin per second, each molecule containing four atoms of iron, which roughly corresponds to 20 mg iron. On the other hand, erythropoiesis is negatively regulated by several cytokines. These are macrophage-derived cytokines, including tumour necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta). All these factors are elevated in the inflammatory state and are implicated in the pathogenesis of anaemia of chronic disease. TNF-alpha has an inhibitory effect on erythroid progenitors either directly or mediated by interferon-beta (INF-beta). IL-1 inhibits erythropoiesis in vivo in mice and in vitro in humans.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis.Rheumatol Int. 1994;14(3):109-13. doi: 10.1007/BF00300811. Rheumatol Int. 1994. PMID: 7839070
-
Effects of interleukin-3 and erythropoietin on in vivo erythropoiesis and F-cell formation in primates.Blood. 1989 Oct;74(5):1571-6. Blood. 1989. PMID: 2477080
-
Effects of monocyte-macrophage colony-stimulating factor (M-CSF) on in vitro erythropoiesis of marrow progenitor cells from patients with renal anemia.Eur J Haematol. 1995 Mar;54(3):147-52. doi: 10.1111/j.1600-0609.1995.tb00205.x. Eur J Haematol. 1995. PMID: 7720833 Clinical Trial.
-
Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation.Nephrol Dial Transplant. 2013 Jul;28(7):1672-9. doi: 10.1093/ndt/gft021. Epub 2013 Mar 6. Nephrol Dial Transplant. 2013. PMID: 23468534 Review.
-
Role of c-Kit and erythropoietin receptor in erythropoiesis.Crit Rev Oncol Hematol. 2005 Apr;54(1):63-75. doi: 10.1016/j.critrevonc.2004.11.005. Crit Rev Oncol Hematol. 2005. PMID: 15780908 Review.
Cited by
-
Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia.Front Cell Infect Microbiol. 2022 Jul 22;12:919352. doi: 10.3389/fcimb.2022.919352. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35937691 Free PMC article.
-
Oral Administration of Ren-Shen-Yang-Rong-Tang 'Ninjin'yoeito' Protects Against Hematotoxicity and Induces Immature Erythroid Progenitor Cells in 5-Fluorouracil-induced Anemia.Evid Based Complement Alternat Med. 2009 Jun;6(2):247-56. doi: 10.1093/ecam/nem080. Epub 2007 Oct 27. Evid Based Complement Alternat Med. 2009. PMID: 18955264 Free PMC article.
-
Statins, inflammation and kidney disease.Nat Rev Nephrol. 2011 May 31;7(7):385-97. doi: 10.1038/nrneph.2011.62. Nat Rev Nephrol. 2011. PMID: 21629228 Review.
-
Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics.BMC Nephrol. 2013 Feb 20;14:44. doi: 10.1186/1471-2369-14-44. BMC Nephrol. 2013. PMID: 23425362 Free PMC article.
-
Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease.Kidney Dis (Basel). 2022 Jan 14;8(2):103-114. doi: 10.1159/000521162. eCollection 2022 Mar. Kidney Dis (Basel). 2022. PMID: 35527989 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials